Expression of BAGE, GAGE, and MAGE Genes in Human Gastric Carcinoma

Clinical Cancer Research

Volumn 2, Issue 9, 1996, Pages 1619-1625

  Li, Jian ^a   Yang, Yi ^a   Fujie, Tatsuro ^a   Baba, Kinya ^a   Ueo, Hiroaki ^b   Mori, Masaki ^a   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Oita Nakamura Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC ANTIMETABOLITE; AZACITIDINE; BAGE PROTEIN, HUMAN; DNA; DRUG DERIVATIVE; GAGE1 PROTEIN, HUMAN; MAGEA1 PROTEIN, HUMAN; MAGEA3 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

AGED; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH; STOMACH TUMOR; TUMOR GENE;

AGED; ANTIGENS, NEOPLASM; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; STOMACH; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030223001     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
2. Coulie, P. G , Brichard, V., Van Pel, Wolfel, T., Schneider, J., Traversari, C., De Plaen, E., Lurquin, C., Szikora, J-P., Renauld, J-C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 190: 35-42, 1994.
3. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L , Topalian, S L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl Acad. Sci. USA, 91: 3515-3519, 1994
4. Bakker, A. B. H., Schreurs, M. W. J., De Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte-lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med., 179: 1005-1009, 1994.
5. Wang, R-F., Robbins, P. F., Kawakami, Y , Kang, X-Q., and Rosenberg, S A. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J Exp. Med., 181: 799-804, 1995.
6. van der Bruggen, P., Traversari, C., Chomez, P , Lurquin, C., De Plaen, E., Van der Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
7. Boel, P., Wildmann, C., Sensi, M. L., Brausseur, R., Renauld, J-C., Coulie, P., Boon, T., and van der Bruggen, P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2: 167-175, 1995
8. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp Med., 182. 689-698, 1995.
9. Coulie, P. G., Lehmann, F., Lethe, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad. Sci. USA, 92: 7976-7980, 1995.
10. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
11. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amer-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
12. Salgaller, M. L., Weber, J. S., Koenig, S., Yannelli, J. R., and Rosenberg, S. A. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunother., 39: 105-116, 1994.
13. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M , Salgaller, M. L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154: 2257-2265, 1995.
14. Salgaller, M L., Afshar, A , Marincola, F. M., Rivoltini, L , Kawakami, Y., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res., 55. 4972-4979, 1995.
15. Toso, J. F., Oei, C., Oshidari, F., Tartaglia, J., Paoletti, E., Lyerly, H. K., Talib, S., and Weinhold, K. J. MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation. Cancer Res., 56: 15-20, 1996.
16. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154. 3961-3968, 1995.
17. Thomas, R. M., and Sobin, L. H. Gastrointestinal cancer. Cancer (Phila.), 75: 154-170, 1995.
18. Jatzko, G., Lisborg, P H., Denk, H., Klimpfinger, M., and Stettner, H. M. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer (Phila.), 76: 1302-1312, 1995.
19. Findlay, M., and Cunningham, D. Chemotherapy of carcinoma of the stomach. Cancer Treat. Rev., 19: 29-44, 1993.
20. Cullinan, S. A., Moertel, C. G., Wieand, H. S., O'Connell, M J., Poon, M. A., Krook, J. E., Maillard, J. A., and Tschetter, L. K. for the North Central Cancer Treatment Group. Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. J. Clin. Oncol., 12: 412-416, 1994.
21. Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J-L., Laurent, C., Naeyaert, J-M., Plagne, R., Deraemaecker, R., Knuth, A., Jager, E., Brasseur, F., Herman, J., Coulie, P G., and Boon, T. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63: 883-885, 1995.
22. Brasseur, F., Marchand, M., Vanwijck, R., Herin, M., Lethe, B., Chomez, P., and Boon, T. Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors. Int. J. Cancer, 52: 839-841, 1992.
23. Coulie, P. G., Weynants, P., Lehmann, F , Herman, J., Brichard, V., Wolfel, T., Van Pel, A., De Plaen, E., Brasseur, F., and Boon, T. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J. Immunother., 14: 104-109, 1993
24. Rimoldi. D , Romero, P , and Carrel, S. The human melanoma antigen-encoding gene, MAGE, is expressed by other tumor cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int. J. Cancer, 54: 527-528, 1993.
25. Weynants, P., Lethe, B., Brasseur, F., Marchand, M., and Boon, T. Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer, 56: 826-829, 1994
26. Patard, J-J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., Francois, P., Abi Aad, A , Van Cangh, P., Abbou, C. C., Chopin, D., and Boon, T. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J Cancer, 64: 60-64, 1995.
27. Brasseur, F., Rimoldi, D., Lienard, D., Lethe, B., Carrel, S., Arienti, F , Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., Vacca, A., Conese, M., Lahaye, T., Degiovanni, G., Deraemaecker, R., Beauduin, M., Sastre, X., Salamon, E., Dreno, B., Jager, E., Knuth, A., Chevreau, C., Siciu, S., Lachapelle, J-M , Pouillart, P., Parmiani, G., Lejeune, F., Cerottini, J-C., Boon, T., and Marchand, M. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer, 63: 375-380, 1995.
28. Inoue, H., Mori, M., Honda, M., Li, J , Shibuta, K., Mimori, K., Ueo, H., and Akiyoshi, T. The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterology, 109: 1522-1525, 1995.
29. Weber, J., Salgaller, M., Samid, D., Johnson, B., Herlyn, M., Lassam, N., Treisman, J., and Rosenberg, S. A. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res., 54: 1766-1771, 1994.
30. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn. J. Surg., 11: 127-129, 1981.
31. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorofoim extraction. Anal. Biochem., 162: 156-159, 1987.
32. Gaugler, B., Van der Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
33. Tokunaga, H., Nakamura, Y., Sakata, K., Fujimori, K., Okubo, M., Sawada, K., and Sakiyama, S Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers Cancer Res., 47: 5616-5619, 1987.
34. Duarte, I , and Llanos, O. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum. Pathol., 12: 237-242, 1981.
35. Mori, M., Sakaguchi, H., Akazawa, K., Tsuneyoshi, M., Sueishi, K., and Sugimachi, K. Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum. Pathol., 26. 504-508, 1995.
36. van der Bruggen, P., Szikora, J-P , Boel, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanoma expressing HLA-Cw1601. Eur. J. Immunol., 24: 2134-2140, 1994
37. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Bocl, P , De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
38. Dong, R., Kimura, A., Okubo, R , Shinagawa, H., Tamai, H., Nishimura, Y., and Sasazuki, T. HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum. Immunol., 35: 165-172, 1992.
39. van Groeningen, C. J., Leyva, A., O'Brien, A. M. P., Gall, H. E., and Pinedo, H. M. Phase I and pharmacokinetic study of 5-aza-2′-deoxycytidine (NSC 127716) in cancer patients Cancer Res , 46: 4831-4836, 1986.